新智元逐条驳斥 AI 泡沫破灭论:OpenAI 融资下调与 Anthropic 评级被误读
新智元逐条核查上周五集中出现的几条消息,认为 OpenAI 融资失败、Anthropic 被评为垃圾级、8000 亿美元计划靠借钱会崩溃等流行解读大多站不住。
新智元逐条核查上周五集中出现的几条消息,认为 OpenAI 融资失败、Anthropic 被评为垃圾级、8000 亿美元计划靠借钱会崩溃等流行解读大多站不住。
据《华尔街日报》报道,机构投资者告知 Anthropic,其 IPO 估值应在约 1.5 万亿至 1.6 万亿美元之间,低于此前 2 万亿美元的估算。报道将下调归因于科技股抛售。

Anthropic 在修订后的 S-1 中披露,公司已签订 8954 亿美元的采购承诺与租赁协议,其中绝大部分与算力和基础设施相关。该信息由 CNBC 记者 Ashley Capoot 报道。

Anthropic 表示,一名恶意行为者利用对 Cursor 市场的访问权限,发布了一个被篡改的 Claude Code 扩展副本,该扩展并非 Anthropic 构建或发布。相关情况由 Felix Rieseberg 在 X 上披露。

Anthropic 在 S-1 文件中表示公司高度依赖台积电在台湾制造的芯片,并就地缘政治紧张局势下的潜在供应中断风险发出警示。该披露由《华尔街日报》记者 Joseph C. Sternberg 报道。

据 The Information 援引消息人士,Nvidia 正洽谈为 AI 云厂商 Nscale 提供数十亿美元信用担保,用于为其债务融资,以开发一座 460MW 数据中心,Anthropic 计划使用该数据中心。报道未披露担保的具体金额和交易进度。
据 Bloomberg 报道,SpaceX 在一份申报文件中将 Anthropic 列为单一最大客户,后者贡献其 Q3 营收的 34.5%,超过美国政府。该信息来自匿名信源,正文未披露更多交易细节。

Techmeme 引述 The Information 的报道称,在 Anthropic 收紧限制后,DeepSeek 与 Moonshot AI 大量依赖 GPT-6 Astra 的蒸馏来训练 Kimi K3.1 Pro、V4.1-Flash 1017 等模型。该条目正文仅列出播客推荐内容,未提供更多训练细节。

Surprise 1: Anthropic acquired a one-person biotech . . . Surprise 2: that person is me Surprise 3: I’m here to tell you all about it Yes, this is what you think it is; after 6 yrs of increasingly loose anonymity: the Professor Oak reveal post …and yes, it has gotten so boring around here that I’m literally doxxing myself to spice up the timeline ------- Ok, allow me to introduce myself. My name is Cody Tranbarger. I mostly tweet, but occasionally find time to dabble in drug dev & starting/building biotechs. My past lives span the VC, crossover, startup continuum; Prof Oak has been my way of keeping a digital foot in those worlds, despite having my physical feet planted elsewhere. The past 18 mo, ‘elsewhere’ was Mithril Medicine, a co. I founded to develop bsAbs for LAMA2-CMD & other ECM-related genetic diseases. Mithril was born out of hands-on building with @MikeNGladstone, @JasonPaulRhodes, @LifeSciVC, & team @atlasventure. Somehow, I made enough half-decent calls along the way (even a broken clock is right twice a day, eh?) to convince them Mithril/I warranted a small seed. While I can hardly rationalize such an outrageously cavalier bet, I’m grateful for it, & I'd partner with Atlas again in a heartbeat. In typical AV fashion, Mithril’s primordial form was virtual, decentralized, & ultra-lean. This stage tends to be short-lived, but for Mithril, it worked surprisingly well, for surprisingly long, thanks in part to the rapid maturation of the AI tools I used liberally. Eventually, Mithril became a bit of an experiment itself - to find the upper bound of how far it could scale as a single operator + a bunch of Claude (+ a stellar bench of part-time consultants). In parallel, I started spending time with @nc_frey, @an1lam, & @CoefficientBio team; and promptly experienced, for the 1st time, AI at the frontier. Soon thereafter, Mithril stopped looking like an experiment, & started looking like a preview of an entirely new operating model. From that spark came “Pipeline-in-a-Person.” The idea immediately resonated when we shared it here back in April; and it was central to the shared vision that led to Anthropic’s acquisition of Mithril, & my joining the team. Why join Anthropic? Three reasons. (1) For Mithril, the programs continue, with more resources & infrastructure behind them, and as much Claude as I can put to work. (2) For me, the chance to start several more programs, & find out how many one person can actually run in parallel - an almost unprecedented luxury for a curious drug hunter. (3) For our mission, a path to institutionalize & scale this new way of working, then put it in the hands of all of biopharma, all over the world - which, candidly, I find the most energizing. Will AI x Bio cure diseases? Unequivocally yes, imo… but not by the route that gets the most airtime. Rather than timeline acceleration & compression, I see orchestration & parallelization as today's low-hanging fruit. Most drug hunters see a handful of go/no-go calls in a career, & spend entirely too much of the rest trading emails (my inbox can attest). Give them the bandwidth to run several programs at once, and the time to focus on scientific judgment, and I’m willing to bet they’ll make better calls. And at scale, better calls translate to more drugs, higher hit rates, broader patient impact, & likely, a disease or 10 or 100 cured. I couldn't be more excited to build toward that future @AnthropicAI. Finally, a heartfelt thank you to BioTwitter/X. The end of anonymity is bittersweet, but if anyone’s earned a proper introduction, you all have. It’s difficult to overstate how much this app has done for me: a decade of education, plenty of friends, many job opportunities, several mentors, a few investors, even a co-founder (fmr). It was the generosity of this community that inspired me to start posting 6 years ago, after just as many years lurking. I hope I’ve been able to pay it forward, in my own small way. But, to be clear, Prof Oak isn’t going anywhere. Same beat, same themes, and now, a front-row seat to drug development at the frontier. Stay tuned for dispatches from the trenches; and remember... Gotta Cure 'Em All
Anthropic 于 10 月 28 日为今年 5 月推出的 Claude for Legal 增加法律工具库,提供一批可直接使用和分享的 Artifacts。
New in Claude for Legal: a gallery of ready-made artifacts for contract review, regulatory horizon scans, cite checks, and more. Start from the built-in example, add your own documents and connectors, and share it with anyone across the business.
据《华尔街日报》报道,参议员 Elizabeth Warren 致信 Dario Amodei,要求 Anthropic 在 11 月 3 日前就四页问题给出详尽答复,内容涉及该公司 S-1 中的生存性风险。信中要求的是逐条书面回应,而非一般性说明。

Techmeme 引述 CNBC 记者 Leslie Picker 的报道,Anthropic 的 S-1 文件显示其截至 6 月 30 日持有 1124 亿美元现金和 193 亿美元短期投资。这一规模超过了除伯克希尔·哈撒韦和 Alphabet 之外的所有美国非银行公司。

《华尔街日报》报道,Anthropic 的 S-1 文件基于 2025 年知识工作的经济价值,隐含超过 40 万亿美元的年度 TAM,但文件中并未明确写出 TAM 一词。这一数字高于 SpaceX 此前给出的 28.5 万亿美元估算。

Anthropic 扩大与美国 GSA 的合作,向联邦、州、地方、部落和领地政府提供 Claude 40% 折扣,估算可节省 10 亿美元。该消息由 Anthropic 发布,Techmeme 转载。

The Information 记者 Stephanie Palazzolo 报道,Anthropic 的 S-1 文件显示其上半年通过运行模型实现 85% 的毛利率。这一数字回应了此前质疑按量付费模型销售难以盈利的观点。

据《华尔街日报》报道,博通 CEO 陈福阳(Hock Tan)在最后时刻进行谈判,同意提高利率并提供贷款担保,以确保银行参与 Anthropic 的 630 亿美元债务交易。报道称,这一安排是这笔大额融资得以推进的关键环节。

Broadcom 与美银、黑石、花旗和摩根士丹利安排了一笔 630 亿美元的交易,通过新的特殊目的载体为 Anthropic 采购芯片提供融资。该消息由 Bloomberg 的 Lynn Doan 报道。正文页面主要为播客推荐内容,未提供更多交易细节。

据 Forbes 的 Anna Tong 报道,Anthropic 的 IPO 文件列出了一项不寻常的继任安排:每位联合创始人都有一份保密的、按顺序排列的最多 10 名继任者名单,且需经五位联合创始人批准。Techmeme 该条目正文主要为播客推荐内容,未提供更多细节。

Matt Levine 在 Bloomberg 撰文分析 Anthropic 的 S-1 文件,指出其治理结构既适合一家有使命驱动色彩的小型合作社,又要满足作为上市公司筹集数十亿美元的需要。Techmeme 页面同时列出多档相关播客,包括 Big Technology Podcast 关于 Anthropic S-1 IPO 申报的紧急节目。

Anthropic 的 S-1 文件显示,其 2026 年上半年资本开支仅 4.82 亿美元,大部分算力通过租赁获得。其资本开支几乎全部外包,对应 7820 亿美元的租赁义务。该信息由 Tim Culpan 在 Culpium 中披露。

据《华尔街日报》报道,Anthropic 的 S-1 文件列出 94 页风险因素,并警告若发生“灾难性”AI 事故,其“危害规模”可能使公司无法获得保险。该披露出现在其上市申报材料中。

据 Axios 记者 Maria Curi 报道,Anthropic 在 S-1 文件中警告潜在投资者,其 AI 安全与倡导立场可能使其面临特朗普政府不成比例且选择性的针对。Techmeme 该条目正文主要为播客推荐内容,未提供 S-1 文件的其他细节。

Anthropic 的 S-1 文件显示,公司 2026 年上半年净亏损 810 亿美元,其中超过 720 亿美元与公司估值上升带来的可转债价值变动有关。据 Financial Times 报道,这部分亏损并非来自经营层面。

Anthropic 在 S-1 文件中披露,IPO 后公司将继续保留公益公司(Public Benefit Corporation)身份,七位联合创始人将通过单一 Class F 股份持有 50.1% 的投票控制权。该信息由路透社的 Deborah Mary Sophia 报道。

Techmeme 援引《华盛顿邮报》报道,成立仅数月、由前 DOGE 员工创办的网络安全公司 Cathedral 称,其使用 AI 智能体在不到 12 小时内攻破了 Anthropic 的内部系统。

据 The Information 报道,Replit 近期将大部分 AI 支出从 Anthropic 转向 OpenAI。此前 Anthropic 取消了折扣,而 OpenAI 在年规模超 1 亿美元的合作中给出了 30% 以上的折扣。

🚨🚨ALERT: ANTHROPIC IS A/B TESTING USAGE LIMITS Many users on X are reporting LOWER usage limits right now. THEY ARE NOT WRONG. We detected an A/B test going on that DECREASES your monthly API-value by ~20% while INCREASING your 5h usage limits by ~20%. This only affects SOME accounts. (1/2)🧵
据 Bloomberg 报道,前 Google CEO Eric Schmidt 在 2021 年参与 Anthropic A 轮融资后持有约 1% 股份,当时公司估值 4.61 亿美元。这一比例约为联合创始人兼 CEO Dario Amodei 所持 2% 的一半。Anthropic 被普遍预计在年底前上市,若按最高 2 万亿美元估值计算,Schmidt 的净资产最多可增加 200 亿美元。

Anthropic 宣布向 Genesis Mission 投入 1.5 亿美元,以加深对科学研究与技术发现的投入。同时,Anthropic 将向 15 个以上联邦机构提供 Claude 及技术支持。